Lucerastat
Lucerastat is a pharmaceutical drug with 6 clinical trials. Currently 1 active trials ongoing. Historical success rate of 100.0%.
Success Metrics
Based on 5 completed trials
Phase Distribution
Phase Distribution
4
Early Stage
0
Mid Stage
2
Late Stage
Highest Phase Reached
Phase 3Trial Status & Enrollment
100.0%
5 of 5 finished
0.0%
0 ended early
1
trials recruiting
6
all time
Detailed Status
Development Timeline
Analytics
Development Status
Trials by Phase
Trials by Status
Recent Activity
A Study to Evaluate the Long-term Safety and Tolerability of Lucerastat in Adult Subjects With Fabry Disease
A Study to Assess the Safety, Tolerability and Pharmacokinetics of Lucerastat (CDP923) After Multiple Dosing in Healthy Subjects
A Study to Assess the Safety and Pharmacokinetics of Lucerastat (OGT 923) in Healthy Subjects
Efficacy and Safety of Lucerastat Oral Monotherapy in Adult Subjects With Fabry Disease
Effect of Cimetidine on the Pharmacokinetics of Lucerastat in Healthy Subjects
Clinical Trials (6)
A Study to Evaluate the Long-term Safety and Tolerability of Lucerastat in Adult Subjects With Fabry Disease
A Study to Assess the Safety, Tolerability and Pharmacokinetics of Lucerastat (CDP923) After Multiple Dosing in Healthy Subjects
A Study to Assess the Safety and Pharmacokinetics of Lucerastat (OGT 923) in Healthy Subjects
Efficacy and Safety of Lucerastat Oral Monotherapy in Adult Subjects With Fabry Disease
Effect of Cimetidine on the Pharmacokinetics of Lucerastat in Healthy Subjects
A Study to Assess the Safety and Tolerability of Lucerastat in Subjects With Fabry Disease
All 6 trials loaded
Drug Details
- Intervention Type
- DRUG
- Total Trials
- 6